International safety notice
Invivoscribe, Inc. LymphoTrack DX - Miseq - teatud partiide mittevastavus
Estonia / EMDDB · EST · May 1, 2024
Key facts
| Title | Invivoscribe, Inc. LymphoTrack DX - Miseq - teatud partiide mittevastavus |
|---|---|
| Regulator | Estonia / EMDDB |
| Country | EST |
| Brand | Invivoscribe, Inc. LymphoTrack DX |
| Manufacturer | INVIVOSCRIBE INC LYMPHOTRACK DX |
| Models | 012343, 91210059, N0000870, N0000813, 91210069, N0000437, 21210359CE, 10222, 010179, 21210319CE, 92121, 013631 and 16 more |
| Date | May 1, 2024 |
| Regulator page | terviseamet.ee |
At a glance
- No Recall
- No Field safety notice
- 10–99 Matching device models in FDA data
- 10–99 Matching catalog numbers in FDA data
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1